Why do guidelines recommend screening for abdominal aortic aneurysms, but not for asymptomatic carotid stenosis? A plea for a randomized controlled trial

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Armando Amilcar Pires Mansilha Rodrigues De Almeida

    Autor

Participantes de fora da FMUP

  • Paraskevas, KI
  • Spence, JD
  • Mikhailidis, DP
  • Antignani, PL
  • Gloviczki, P
  • Eckstein, HH
  • Spinelli, F
  • Stilo, F
  • Saba, L
  • Poredos, P
  • Dardik, A
  • Liapis, CD
  • Faggioli, G
  • Pini, R
  • Jezovnik, MK
  • Sultan, S
  • Musia, P
  • Goudot, G
  • Lavenson, GS
  • Jawien, A
  • Blinc, A
  • Myrcha, P
  • Fernandes, JFE
  • Geroulakos, G
  • Kakkos, SK
  • Knoflach, M
  • Proczka, RM
  • Capoccia, L
  • Rundek, T
  • Svetlikov, AS
  • Silvestrini, M
  • Ricco, JB
  • Davies, AH
  • Di Lazzaro, V
  • Suri, JS
  • Lanza, GTN
  • Fraedrich, G
  • Zeebregts, CJ
  • Nicolaides, AN

Unidades de investigação

Abstract

Background: Current guidelines do not recommend screening for asymptomatic carotid artery stenosis (AsxCS). The rationale behind this recommendation is that detection of AsxCS may lead to an unnecessary carotid intervention. In contrast, screening for abdominal aortic aneurysms is strongly recommended.Methods: A critical analysis of the literature was performed to evaluate the implications of detecting AsxCS.Results: Patients with AsxCS are at high risk for future stroke, myocardial infarction and vascular death. Population-wide screening for AsxCS should not be recommended. Additionally, screening of high-risk in-dividuals for AsxCS with the purpose of identifying candidates for a carotid intervention is inappropriate. Instead, selective screening for AsxCS should be considered and should be viewed as an opportunity to identify individuals at high risk for atherosclerotic cardiovascular disease and future cardiovascular events for the timely initiation of intensive medical therapy and risk factor modification.Conclusions: Although mass screening should not be recommended, there are several arguments suggesting that selective screening for AsxCS should be considered. The rationale supporting such selective screening is to optimize risk factor control and to initiate intensive medical therapy for prevention of future cardiovascular events, rather than to identify candidates for an intervention.

Copyright © 2022 Elsevier B.V. All rights reserved.

Dados da publicação

ISSN/ISSNe:
1874-1754, 0167-5273

International Journal of Cardiology  Elsevier Ireland Ltd

Tipo:
Review
Páginas:
406-412
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 6

Citações Recebidas na Scopus: 14

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Asymptomatic carotid atherosclerosis; Screening; Carotid stenosis; Carotid plaque burden; Stroke; Guidelines

Proyectos asociados

Endovascular Treatment of Aortic Arch Aneurysms

Investigador Principal: Armando Amilcar Pires Mansilha Rodrigues de Almeida

Estudo Clínico Académico (Aneurysms) . 2020

The role of infrared thermography in predicting diabetic foot outcomes

Investigador Principal: Armando Amilcar Pires Mansilha Rodrigues de Almeida

Estudo Clínico Académico (diabetic foot) . 2021

Endovascular solutions for type IA endoleak after endovascular aneurysm repair

Investigador Principal: Armando Amilcar Pires Mansilha Rodrigues de Almeida

Estudo Clínico Académico . 2021

Intermittent Claudication: Importance of Supervised Exercise Programme

Investigador Principal: Armando Amilcar Pires Mansilha Rodrigues de Almeida

Estudo Clínico Académico . 2021

Endovascular Aneurysm Repair - Strategies and Outcomes in Hostile Anatomies

Investigador Principal: Armando Amilcar Pires Mansilha Rodrigues de Almeida

Estudo Clínico Académico . 2022

Citar a publicação

Partilhar a publicação